Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride

Description

This prescription medication combines bismuth subcitrate potassium (140 mg), metronidazole (125 mg), and tetracycline hydrochloride (125 mg) in oral capsules. It's used to treat infections caused by Helicobacter pylori bacteria, often in combination with other therapies for stomach ulcers or gastritis. Take as directed by a doctor. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride — ANDA 217511 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217511

Tags

  • fda
  • drug-safety
  • drug-manufacturers
  • public-health
  • pharmaceuticals

Topics

Categories